ventrus biosciences (VTUS)

- nasdaq
$2.66 May 17, 2013-04:00 PM ET
Chart_VTUS_365_13.jpg
Chart Type 1D 5D 1M 3M 6M 1Y 2Y 5Y

 

Prev Close: $2.64 Day's Range: $2.64 - $2.69
Open: $2.66 52wk Range: $1.99 - $12.88
P/E Ratio: 0 Volume: 48,915
Beta: 0.61 Avg Vol (3m): 91,540
Div & Yield: Market Cap(Mil.): 52
EPS (ttm): -1.46 P/E (ttm): -1.82

ventrus biosciences News
  • Federman & Sherwood Files Securities Class Action Lawsuit Against Ventrus Bioscences
    5/12/2013
  • Ventrus Biosciences Announces Poster Presentation On Quality Of Compounded Topical Diltiazem Hydrochloride Formulations
    3/1/2013
  • Ventrus Biosciences Announces Full Exercise Of Overallotment Option By Underwriters
    2/7/2013
  • Ventrus Biosciences Announces $20 Mln Financing
    1/30/2013
  • Ventrus Biosciences Posts Q3 Operating Loss Of $5.4 Mln
    11/13/2012
  • Ventrus Biosciences Expects To File NDA For Diltiazem In Q4 Of 2013
    11/5/2012

Next 10 Headlines
Copyright © 2013 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service.
Privacy   |   Feedback   |   Sitemap